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SUMMARY
Demyelinating diseases are characterized by a loss
of oligodendrocytes leading to axonal degeneration
and impaired brain function. Current strategies
used for the treatment of demyelinating disease
such as multiple sclerosis largely rely on modulation
of the immune system. Only limited treatment op-
tions are available for treating the later stages of
the disease, and these treatments require regenera-
tive therapies to ameliorate the consequences
of oligodendrocyte loss and axonal impairment.
Directed differentiation of adult hippocampal neural
stem/progenitor cells (NSPCs) into oligodendrocytes
may represent an endogenous source of glial cells for
cell-replacement strategies aiming to treat demyelin-
ating disease. Here, we show that Ascl1-mediated
conversion of hippocampal NSPCs into mature
oligodendrocytes enhances remyelination in a diph-
theria-toxin (DT)-inducible, geneticmodel for demye-
lination. These findings highlight the potential of tar-
geting hippocampal NSPCs for the treatment of
demyelinated lesions in the adult brain.
INTRODUCTION
Neural stem/progenitor cells (NSPCs) reside in two distinct re-
gions of the adult mammalian brain: the subventricular zone
(SVZ) and the hippocampal dentate gyrus (DG) (Gage, 2000).
Harnessing the regenerative capacity of endogenous adult
NSPCs can contribute to brain repair (Lindvall and Kokaia,
2006). Previous reports have suggested the remyelination poten-
tial of NSPC-derived oligodendrocytes in areas neighboring the
adult SVZ (Menn et al., 2006; Nakatani et al., 2013; Rafalski
et al., 2013). However, in striking contrast to the SVZ, NSPCs
in the DG do not spontaneously differentiate into oligodendro-
cytes and remyelination is limited after injury in the hippocampal
formation. The hippocampus plays a pivotal role in certain forms
of learning and memory and is commonly affected in demyelin-
ating diseases such as multiple sclerosis as well as other brain
disorders, including traumatic brain injury, epilepsy, Alzheimer’s
disease, and schizophrenia (Chambers and Perrone-Bizzozero,
2004; Hemanth Kumar et al., 2014; Meier et al., 2004; Noble,
2004; Yang et al., 2009; Chiaravalloti and DeLuca, 2008; Geurts
et al., 2007), underlining the need for therapies that promote re-
myelination within this brain region (Franklin and Ffrench-Con-
stant, 2008). Overexpression of the transcription factor (TF)
Ascl1 converts hippocampal NSPCs into oligodendrocytic cells
in vivo (Jessberger et al., 2008), but their potential for remyelina-
tion remains unknown (Goldman and Natesan, 2008; Jessberger
and Gage, 2009). Thus, we here evaluate the remyelination
capacity of hippocampal NSPCs by in vivo reprogramming of
hippocampal NSPCs into oligodendrocytes in a mouse model
of demyelinating disease.
RESULTS
Overexpression of Ascl1, Olig2, or Sox10 TFs Directs
Hippocampal NSPC Differentiation toward the
Oligodendrocyte Lineage In Vivo
To identify novel TFs that direct NSPC progeny toward the oligo-
dendrocyte lineage, we focused on a developmental pathway
that plays an important role in oligodendrogenesis during brain
development (Nakatani et al., 2013). Ascl1 is required for oligo-
dendrogenesis through a genetic interaction with Olig2, an
essential transcriptional regulator of oligodendrocyte fate (Petry-
niak et al., 2007; Zhou and Anderson, 2002). Furthermore, Olig2
binds regulatory elements to induce the expression of Sox10, a
TF that is required for expression of myelin genes (Ku¨spert
et al., 2011; Stolt et al., 2002). First, we transduced adult hippo-
campal NSPCs in vitro using retroviruses overexpressing Ascl1,
Olig2, or Sox10 and analyzed cell fates under differentiating con-
ditions. We found that overexpression of either of these TFs
increased oligodendrocyte differentiation of adult NSPCs when
compared to cells infected with control retroviruses (Figures
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S1A–S1C). Sox10 was the most potent inducer of oligodendro-
cyte differentiation, whereas Ascl1 and Olig2 overexpression
only modestly increased oligodendrogenesis in vitro (Fig-
ure S1D). Given the importance of niche-derived factors for
directed differentiation of hippocampal NSPCs (Goldman and
Natesan, 2008; Jessberger and Gage, 2009), we injected
Ascl1-, Olig2-, or Sox10-expressing retroviruses directly into
the DG of adult mice to determine their reprogramming effi-
ciencies in vivo. Interestingly, Olig2 and Sox10 TFs were able
to significantly enhance NSPC differentiation into oligodendro-
cytes in vivo (Figures 1A–1D), albeit at lower efficiencies than
Ascl1. These findings indicate that the fate potential of hippo-
campal NSPCs remains highly plastic, as the induction of a
developmental genetic program at different stages redirects
the fate of adult NSPCs toward the oligodendrocyte lineage.
Spontaneous Remyelination Is Limited in the
Hippocampus after DT-Induced Ablation of Mature
Oligodendrocytes
Next, we developed an inducible model for focal demyelination
to test if directed differentiation of NSPCs into oligodendrocytes,
using themost potent TF Ascl1, can enhance remyelination in the
hippocampus. To ablate oligodendrocytes in the adult brain,
we crossed mice expressing an oligodendrocyte-specific Cre
recombinase (MOG-Cre) with mice harboring a Cre-inducible
diphtheria toxin receptor (DTR) (Buch et al., 2005). The resulting
oDTRmice (MOGCre+//DTR+/) express the DTR specifically in
mature oligodendrocytes, rendering these cells sensitive to DT-
induced cell death (Figure 2A). For focal demyelination, we ster-
eotactically injected DT into the DG of adult oDTR mice. We
observed a substantial decrease in myelin basic protein (MBP)
levels within the hippocampus of oDTR mice when compared
to their littermate controls (Con:MOGCre//DTR+/) (Figure 2B).
These results validate this novel DT-inducible genetic approach
for focal ablation of oligodendrocytes and subsequent demyelin-
ation in discreet brain areas. Myelin levels remained significantly
lower in oDTR mice compared to controls 3, 6, and 10 weeks af-
ter injury and did not increase over time, indicating that focal DT
injection leads to chronic demyelination in oDTR mice (Figures
2C–2E). In support of this finding, we observed that oligodendro-
cyte precursor cell (OPC) numbers remained unchanged in the
hilus 3 weeks after DT injection (Figures S2A–S2C). In addition,
the fate of newborn cells was not altered after demyelination,
as in both oDTR and control mice, the vast majority of NSPCs
differentiated into neurons (Figures S2D–S2F), suggesting that
demyelination of the hippocampus is not sufficient to direct the
fate of NSPCs into oligodendrocytes. Taken together these
results indicate that endogenous remyelination is limited in
Figure 1. Retroviral Overexpression of Ascl1, Olig2, and Sox10 in Adult Hippocampal NSPCs In Vivo
(A) Wild-type adult mice were injected with control, Ascl1-, Olig2-, or Sox10-overexpressing retroviruses into the DG and analyzed 3 weeks later. The fate of
labeled NSPCs was determined by staining for oligodendroglial (OLIG2 or NG2, red) and neuronal (DCX, red) markers (n = 3 for each TF).
(B) Scheme describing the experimental setup.
(C) Graph showing the percentage of GFP-expressing cells positive for the oligodendrocyte markers OLIG2 or NG2 for each condition (>100 cells were phe-
notyped per condition).
(D) Overexpression of Olig2 or Sox10 in hippocampal NSPCs increases oligodendrocyte differentiation by 6.8-fold and 2.9-fold, respectively. However, many
NSPCs differentiate into neurons despite Olig2 and Sox10 overexpression, although neuronal differentiation appears to be abnormal as shown by the aberrant
morphology of the dendritic processes.
Error bars represent mean ± SEM. Scale bars represent 40 mm. Nuclei were stained with DAPI (blue).
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the DG of the hippocampus following the ablation of mature
oligodendrocytes.
Directed Differentiation of NSPCs into
Oligodendrocytes Increases Myelin Levels in the Adult
Hippocampus after Injury
To evaluate the remyelination potential of fate-directed hippo-
campal NSPC progeny, we injected Ascl1-IRES-GFP expressing
retroviruses into the DG of demyelinated oDTR mice to convert
the differentiation of NSPCs into oligodendrocytes, as this TF
showed the highest reprogramming efficiency. We found that
in a focally demyelinated hippocampus, Ascl1 overexpression
efficiently converted NSPCs into oligodendrocytes (95.25% ±
0.84%) when retroviruses were co-injected into the DG together
with DT toxin to induce demyelination. NSPC-derived oligoden-
drocytes (GFP+/OLIG2+) were observed throughout the demye-
linated hilus of the DG but remained within the DG boundaries
(Figure 3A). Demyelination of the hippocampus did not alter pro-
liferation levels of converted NSPCs, and proliferation of GFP-
negative, endogenous OPCs was not significantly enhanced in
Figure 2. Focal Ablation of Oligodendrocytes in the Hippocampus of Adult oDTR Mice
(A) The oDTR mouse model was generated by crossing DTR mice with MOG-Cre mice to allow for DT-inducible ablation of oligodendrocytes and subsequent
demyelination in the adult brain.
(B) Stereotactic delivery of DT leads to focal ablation of oligodendrocytes. Loss of myelin (MBP, white) was restricted to the hippocampus of oDTR mice after
injection of 0.5 ng DT in the DG. Control mice lacking MOG-Cre expression do not express the DTR, rendering them insensitive to DT-mediated ablation of
oligodendrocytes.
(C) oDTR and Con mice were injected with DT in the DG and MBP levels (red) in the hilus of the DG were determined 3, 6, and 10 weeks after the injections.
(D) Scheme describing the experimental setup.
(E) Graphs showing the quantification of hilar MBP levels in oDTR and Con mice at different time points. The left panel shows %MBP area normalized to control.
The right panel shows measured %MBP areas. (oDTR n = 4 and Con n = 3, for each time point).
Error bars represent mean ± SEM. Scale bars represent 10 mm (B) and 40 mm (C). Nuclei were stained with DAPI (blue). GCL, granule cell layer.
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GFP+ and GFP areas in oDTR mice (Figure S3). Over time, the
NSPC-derived oligodendrocytes matured as determined by the
expression of early (NG2), intermediate (CNPase), and late oligo-
dendroglial lineage markers (MBP) at 3, 6, and 10 weeks after
injury (Figures S4A–S4C). Furthermore, we observed an increase
over time in oligodendrocyte process length of GFP-expressing
cells (Figure 3B), a feature associated with maturing oligoden-
drocyte morphology.
To examine the remyelination potential of NSPC-derived oli-
godendrocytes, we analyzed the extent of demyelination in the
virus-infected regions of the hilus at 3, 6, and 10 weeks after
injury in oDTR and control mice (Figure 3D). At 3 weeks after in-
jection, we observed a significant reduction in myelin levels in
oDTR mice, similar to levels we observed in oDTR mice that
were not co-injected with Ascl1-expressing virus (Figures 2C
and 3C). However, at 6 and 10 weeks after injury, we observed
a striking increase in myelin levels in the hilus of oDTR mice,
reaching levels comparable to MBP levels observed in control
mice that are not sensitive to DT-mediated demyelination (Fig-
ures 3C–3E). These data suggest that NSPC-derived oligoden-
drocytes mature within the DG niche and enhance remyelination
after injury.
Figure 3. Directed Differentiation of Adult NSPCs Restores Hippocampal Myelination after Focal Ablation of Oligodendrocytes
(A) oDTR mice were co-injected with Ascl1-IRES-GFP expressing retroviruses and DT into the DG. Ascl1-overexpressing NSPCs (GFP positive, green) differ-
entiate into oligodendrocytes (OLIG2 positive, red) and extend processes throughout the demyelinated hilus.
(B) The total process length of NSPC-derived oligodendrocytes was measured at 3, 6, and 10 weeks after injection into the hilus of oDTR mice. Example pictures
show Ascl1-IRES-GFP expressing cells at different time points (GFP, 3D volumes rendered in green). Graph shows quantification of total process length (oDTR
n = 4 for each time point, total of 48 cells).
(C) oDTR and Con mice were co-injected with Ascl1-IRES-GFP-expressing retroviruses (green) and DT into the DG, and MBP levels (red) were determined in the
virus-infected regions within the hilus of the DG at 3, 6, and 10 weeks after the injections.
(D) Scheme describing the experimental setup.
(E) Graphs showing the quantification of hilar MBP levels in oDTR and Con mice at different time points. The left panel shows %MBP area normalized to control.
The right panel shows measured %MBP areas. (oDTR n = 4 and Con n = 3, for each time point).
Error bars represent mean ± SEM. Scale bars represent 10 mm (A) and 40 mm (C). Nuclei were stained with DAPI (blue).
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NSPC-Derived Oligodendrocytes Myelinate Axons and
Enhance Remyelination in the Adult Hippocampus after
Injury
To determine the contribution of NSPC-derived oligodendro-
cytes to enhanced remyelination in oDTR mice after injury, we
quantified MBP levels in GFP+ and GFP hilar regions within
the same animals. MBP levels were increased by up to 34% in
regions containing Ascl1-IRES-GFP-expressing oligodendro-
cytes 6 and 10 weeks after injection (Figures 4A and 4B), indi-
cating that fate-directed NSPC-derived oligodendrocytes are
responsible for the recovery of myelination after injury. To
directly show that these cells enwrap axons with myelin sheaths,
we imaged Ascl1-IRES-GFP-expressing oligodendrocytes by
immuno-electron microscopy. Strikingly, serial electron micro-
graphs of Ascl1-IRES-GFP-expressing cells revealed the pres-
ence of myelin sheaths enwrapping axons in the hilus of oDTR
mice 10 weeks after injury (Figures 4C–4E). Thus, these findings
clearly demonstrate that directed differentiation of endogenous
hippocampal NSPCs into myelinating oligodendrocytes en-
hances remyelination of the hippocampus after injury.
DISCUSSION
Previous studies have described the region-specific remyelina-
tion potential of cells derived from SVZ NSPCs, endogenous
OPCs, and transplanted oligodendrocytic cells in distinct brain
areas including the striatum and corpus callosum (Huang et al.,
2011; Nakatani et al., 2013; Picard-Riera et al., 2002; Rafalski
et al., 2013; Yang et al., 2013). We report that in the hippocam-
pus, spontaneous remyelination was largely absent after demy-
elinating injury. To induce focal demyelination within the adult
hippocampus, we established a novel model of genetic demye-
lination based on the oDTR mouse line allowing for DT-induced,
focal ablation of oligodendrocytes. This approach is well suited
for modeling oligodendrocyte loss and cell-replacement strate-
gies as it does not rely on an immune response to induce
Figure 4. NSPC-Derived Oligodendrocytes Remyelinate Axons after Injury
(A) MBP levels were measured in neighboring GFP+ and GFP regions in the hilus of oDTRmice 3, 6, and 10 weeks after co-injection of Ascl1-IRES-GFP and DT
toxin. Representative image showing the maximum projection of inverted MBP staining with a dashed outline of the GFP+ region.
(B) Graph showing the fold change in %MBP area in GFP+ regions compared to GFP regions. Note that when normalized to min (25%) and max (65%) MBP
area, a fold change of 1.14 corresponds to a 34.7% increase in MBP in the GFP+ region (oDTR n = 4, for each time point).
(C) Electron microscopy analysis of remyelinating GFP+ oligodendrocytes in the hilus of oDTR mice 10 weeks after injury. A light microscopy image of the DAB
stained GFP+ hilar cell that was analyzed by electron microscopy is shown. In addition to interactions close to the soma (arrow), processes extend over greater
distances to ensheath axons (arrowheads).
(D) An electron micrograph showing a process extending from the soma of the immunoperoxidase-labeled GFP+ oligodendrocyte (arrow) and ensheathing the
axon. In the corresponding high-magnification serial electron micrographs, note the processes forming the initial myelin wrap extending from the NSPC-derived,
GFP-labeled cell.
(E) An electron micrograph showing a process extending from the soma of the immunoperoxidase-labeled GFP+ oligodendrocyte (arrowheads) toward an axon
5 mm away. Serial electron micrographs (right) show the process approaching and eventually ensheathing the axon.
(F) Schematic representation of the main findings.
Error bars represent mean ± SEM. Scale bars represent 40 mm (A), 10 mm (C), 2 mm (D and E), and 0.5 mm (D0 and E0 ). Nuclei were stained with DAPI (blue).
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demyelination (Locatelli et al., 2012). After focal ablation of oligo-
dendrocytes, we did not observe an increase in OPC numbers or
spontaneous remyelination in the hippocampus. In addition, we
found that neurogenesis levels were unchanged and that oligo-
dendrogenesis was not spontaneously induced in the demyeli-
nated hippocampus. These findings are supported by previous
studies showing that remyelination after oligodendrocyte abla-
tion does not occur equally throughout the brain (Locatelli
et al., 2012; Pohl et al., 2011) and that certain regions, including
the hippocampus, do not display significant levels of sponta-
neous remyelination after injury (Deverman and Patterson,
2012). This is of particular importance, as individuals suffering
from demyelinating diseases such as multiple sclerosis or other
diseases that impact myelination, such as traumatic brain injury
and epilepsy, often show demyelination in temporal lobe regions
and are affected by hippocampus-dependent cognitive deficits,
underlining the need for therapies that promote remyelination
within this brain region (Chambers and Perrone-Bizzozero,
2004; Hemanth Kumar et al., 2014; Meier et al., 2004; Noble,
2004; Benedict et al., 2009; Yang et al., 2009; Chiaravalloti and
DeLuca, 2008; Geurts et al., 2007). Therefore directed differenti-
ation of hippocampal NSPCs into oligodendrocytes that mature,
stably integrate, and enhance remyelination in the lesioned DG
represents a novel approach that harnesses the fate plasticity
of endogenous NSPCs for glial cell replacement.
Notably, we show that directed differentiation of NSPCs into
oligodendrocytes can be achieved within the adult hippocampus
by retroviral overexpression of Ascl1, Olig2, or Sox10 TFs, which
are known to play pivotal roles during brain development to
induce oligodendrocyte lineage specification and maturation.
Thus, the activation of this developmental genetic program in
hippocampal NSPCs is sufficient to switch NSPC fate and to
promote oligodendrogenesis. Future studies aiming to identify
small molecules that can activate this transcriptional pathway
in adult NSPCs will be of great interest to promote oligodendro-
cyte differentiation after injury without using retroviruses, as well
as to develop strategies that promote migration of hippocampal
NSPCs to other brain regions within the temporal lobe.
Importantly, we used several complementary approaches
including electron microscopy to show that Ascl1-mediated
fate conversion of hippocampal NSPCs into mature, myelinating
oligodendrocytes enhances remyelination in the DG after injury
(Figure 4F). Thus, the data shown here represent a proof of
concept for the use of endogenous NSPCs for glial repair within
the adult hippocampus.
EXPERIMENTAL PROCEDURES
Animals and Stereotactic Injections
All animal experiments were approved by the veterinary office of the Canton of
Zurich, Switzerland. The DTR and MOG-Cre mouse lines crossed to generate
oDTR mice have previously been described (Buch et al., 2005). Retroviruses
were produced according to Zhao et al. (2006). Adult oDTR and Con mice
(6–9 weeks) were injected in the DG with 0.5 ng DT (Calbiochem) and/or
Ascl1-IRES-GFP-expressing retroviruses and/or control IRES-GFP-express-
ing retroviruses, diluted in a final volume of 1.5 ml PBS, according to a
previously described protocol (Knobloch et al., 2013). Adult wild-type mice
(6–9 weeks) were injected in the DG with Ascl1-IRES-GFP, Olig2-IRES-CFP,
or Sox10-IRES-GFP expressing retroviruses diluted in 1.5 ml PBS. Animals
were killed at 3, 6, or 10 weeks after injection as indicated. Brains were cut
into 40-mm-thick free-floating sections, and stainings were performed as
described previously (Knobloch et al., 2013). Detailed protocols can be found
in the Supplemental Experimental Procedures.
Cell Culture
Hippocampal NSPCs were isolated from 6- to 8-week-old C57Bl/6 mice as
previously described (Bracko et al., 2012). To analyze the effects of oligoden-
droglial TF overexpression on NSPC differentiation in vitro, adult NSPCs were
infected with control IRES-GFP, Ascl1-IRES-GFP, Olig2-IRES-CFP, or Sox10-
IRES-GFP expressing retroviruses and cultured for 48 hr before induction of
differentiation. Differentiation was induced by growth factor withdrawal in
DMEM/F12 supplemented with B27, heparin (5 m/ml), triiodo-L-thyronine
(T3; 30 ng/ml, Sigma-Aldrich) and L-thyroxine (T4; 40 ng/ml, Sigma-Aldrich).
Image Analysis
Myelination quantification was performed on brain sections stained with MBP
antibodies, and 20-mm sections of the DG were imaged by confocal micro-
scopy (SP2, Leica). Maximum projections of the confocal stacks were thresh-
olded using ImageJ (NIH), and the area of MBP staining was measured as
a percentage value. For each injected animal, 633 images of three to four
separate regions of the DG were analyzed and the%MBP area was averaged.
For quantifications of virus-infected regions, GFP+ areas were traced in all im-
ages and the %MBP area quantification was restricted to the traced area. For
co-localization experiments and cell number quantifications, confocal micro-
scopy (SP2, Leica) was performed followed by analysis using ImageJ and
Imaris (Bitplane). The NeuronJ plugin for ImageJ was used to measure total
process length of GFP+ oligodendrocytes. Photoshop (Adobe) and Imaris
were used for contrast enhancements, 3D rendering, and color adjustments.
Detailed protocols can be found in the Supplemental Experimental
Procedures.
Electron Microscopy
Ten weeks after injury, oDTR mice were transcardially perfused with fixative.
Sections were then blocked and incubated overnight at 4C in the primary
antibody (rabbit a-GFP; 1:500; Invitrogen). Sections were washed and then
incubated for 4 hr at 25C with the secondary antibody (biotinylated goat
a-rabbit; 1:200; Jackson Laboratories), followed by a 3,3-diaminobenzidine
(DAB) peroxidase reaction (Vector Laboratories Kit, 10 min). After dehydration
in ascending concentrations of ethanol and acetone, sections were lifted into
resin (Durcupan ACM, Fluka) and left overnight (25C). After locating Ascl1-
IRES-GFP-expressing oligodendrocytes at the light-microscopic level, serial
ultrathin sections (70-nm thick) were cut and collected onto Formvar-coated,
single-slot copper grids. A Philips CM10 transmission electron microscope
and a digital camera (Morada SIS, Olympus) were used to collect serial images
of the labeled cells. Detailed protocols can be found in the Supplemental
Experimental Procedures.
Statistical Analysis
Statistical analyses were performed using Excel (Microsoft). Two-sample
t tests were used for all comparisons, except for Figure 4B, where a one-sam-
ple t test was used (significance was determined compared to a hypothetical
mean of 1). Differences were considered significant at p < 0.01.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at http://dx.doi.org/
10.1016/j.celrep.2015.05.024.
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